About Cigna Corporation (NYSE:CI)
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company's segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate. Its Global Health Care segment aggregates the commercial and Government operating segments. Its commercial operating segment encompasses the United States commercial and certain international healthcare businesses serving employers and their employees, other groups, and individuals. Its Global Supplemental Benefits segment offers supplemental health, life and accident insurance products in selected international markets and in the United States. Its Group Disability and Life segment provides group long-term and short-term disability insurance, group life insurance, accident and specialty insurance and related services.
Industry, Sector and Symbol:
- Sector: Finance
- Industry: Managed Health Care
- Sub-Industry: Managed Health Care
- Symbol: NYSE:CI
- CUSIP: 12550910
- Web: www.cigna.com
- Market Cap: $46.86849 billion
- Outstanding Shares: 251,778,000
- 50 Day Moving Avg: $185.32
- 200 Day Moving Avg: $170.46
- 52 Week Range: $115.03 - $193.00
Sales & Book Value:
- Trailing P/E Ratio: 21.34
- Foreward P/E Ratio: 16.20
- P/E Growth: 1.33
- Annual Revenue: $40.53 billion
- Price / Sales: 1.15
- Book Value: $57.56 per share
- Price / Book: 3.21
- Annual Dividend: $0.04
- Dividend Yield: 0.0%
- EBITDA: $4.21 billion
- Net Margins: 5.55%
- Return on Equity: 17.40%
- Return on Assets: 4.04%
- Debt-to-Equity Ratio: 0.32%
- Current Ratio: 0.40%
- Quick Ratio: 0.40%
- Average Volume: 1.19 million shs.
- Beta: 0.43
- Short Ratio: 2.3
Frequently Asked Questions for Cigna Corporation (NYSE:CI)
What is Cigna Corporation's stock symbol?
Cigna Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI."
How often does Cigna Corporation pay dividends? What is the dividend yield for Cigna Corporation?
Cigna Corporation announced a quarterly dividend on Wednesday, February 22nd. Stockholders of record on Friday, March 10th will be paid a dividend of $0.04 per share on Monday, April 10th. This represents a $0.16 annualized dividend and a dividend yield of 0.09%. The ex-dividend date of this dividend is Wednesday, March 8th. View Cigna Corporation's Dividend History.
How will Cigna Corporation's stock buyback program work?
Cigna Corporation announced that its Board of Directors has initiated a share buyback plan on Sunday, June 4th 2017, which authorizes the company to repurchase $3,700,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 9.8% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's board of directors believes its shares are undervalued.
How were Cigna Corporation's earnings last quarter?
Cigna Corporation (NYSE:CI) posted its quarterly earnings data on Friday, August, 4th. The company reported $2.91 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $2.48 by $0.43. The business had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The company's revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.98 earnings per share. View Cigna Corporation's Earnings History.
When will Cigna Corporation make its next earnings announcement?
What guidance has Cigna Corporation issued on next quarter's earnings?
Cigna Corporation issued an update on its FY17 earnings guidance on Friday, August, 4th. The company provided earnings per share guidance of $9.75-10.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.78.
Where is Cigna Corporation's stock going? Where will Cigna Corporation's stock price be in 2017?
14 brokerages have issued 12-month target prices for Cigna Corporation's stock. Their predictions range from $174.00 to $221.00. On average, they expect Cigna Corporation's share price to reach $190.62 in the next twelve months. View Analyst Ratings for Cigna Corporation.
What are analysts saying about Cigna Corporation stock?
Here are some recent quotes from research analysts about Cigna Corporation stock:
- 1. According to Zacks Investment Research, "Cigna’s shares have outperformed the industry year to date. The company is poised for long-term growth on the back of its robust Global Supplemental business, growing Government business and increasing membership. A strong capital position and resumption of share buyback are other positives. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised upward over the last 90 days. Cigna is engaged in a legal tussle with Anthem and thus the termination fee and other charges that it were to receive from the latter remain uncertain. Increase in benefits and expenses continue to bother us." (10/9/2017)
- 2. Jefferies Group LLC analysts commented, "CI reported Q2:17 adjusted EPS of $2.91 (GAAP $3.15), compared to OPCO’s estimate of $2.46 and Street consensus of $2.45. Adjusted results exclude $0.13 of realized investment gains and $0.18 from merger-related tax benefits, offset by $0.07 of amortization expense. The beat was driven by the Healthcare segment, with the Commercial MCR of 78.7% outperforming OPCO/Street estimates by 200/160 bps. Due to the beat, the company raised FY2017 EPS guidance to $9.75-$10.05 vs. $9.35-$9.85, with all three segment outlooks growing by $15-$40M." (8/4/2017)
Who are some of Cigna Corporation's key competitors?
Who are Cigna Corporation's key executives?
Cigna Corporation's management team includes the folowing people:
- Isaiah Harris Jr., Independent Chairman of the Board
- David M. Cordani, President, Chief Executive Officer, Director
- Eric P. Palmer, Chief Financial Officer, Executive Vice President
- CHRISTOPHER HOCEVAR, President, Strategy, Segments and Solutions
- Matthew G. Manders, President - Government & Individual Programs and Group Insurance
- Jason Dominic Sadler, President - International Markets.
- MICHAEL TRIPLETT, is President, U.S. Markets
- Mark L. Boxer, Global Chief Information Officer, Executive Vice President
- Lisa R. Bacus, Executive Vice President, Chief Marketing Officer, Chief Customer Officer
- Nicole S. Jones, Executive Vice President, General Counsel
Who owns Cigna Corporation stock?
Cigna Corporation's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Pensionfund DSM Netherlands (0.01%), Pensionfund Sabic (0.00%) and Eqis Capital Management Inc. (0.00%). Company insiders that own Cigna Corporation stock include David Cordani, Herbert A Fritch, Isaiah Harris Jr, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones, Thomas A Mccarthy and William D Zollars. View Institutional Ownership Trends for Cigna Corporation.
Who bought Cigna Corporation stock? Who is buying Cigna Corporation stock?
How do I buy Cigna Corporation stock?
Shares of Cigna Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cigna Corporation's stock price today?
MarketBeat Community Rating for Cigna Corporation (NYSE CI)MarketBeat's community ratings are surveys of what our community members think about Cigna Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Cigna Corporation stock can currently be purchased for approximately $184.99.
Consensus Ratings for Cigna Corporation (NYSE:CI) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||2 Hold Ratings, 12 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.86)|
|Consensus Price Target: ||$190.62 (3.04% upside)|Consensus Price Target History for Cigna Corporation (NYSE:CI)
Analysts' Ratings History for Cigna Corporation (NYSE:CI)
(Data available from 10/17/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|10/16/2017||BMO Capital Markets||Initiated Coverage||Market Perform||N/A|
|10/13/2017||Jefferies Group LLC||Boost Price Target||Buy||$201.00 -> $221.00||N/A|
|9/17/2017||Piper Jaffray Companies||Reiterated Rating||Buy||$191.00||Low|
|8/17/2017||Morgan Stanley||Boost Price Target||Overweight||$188.00 -> $195.00||Low|
|8/9/2017||Royal Bank Of Canada||Reiterated Rating||Buy||$185.00||High|
|8/7/2017||Citigroup Inc.||Boost Price Target||Buy||$185.00 -> $198.00||Low|
|8/7/2017||Deutsche Bank AG||Boost Price Target||Buy||$180.00 -> $190.00||Low|
|8/4/2017||Credit Suisse Group||Reiterated Rating||Buy||$196.00||High|
|6/23/2017||Bank of America Corporation||Boost Price Target||Buy||$193.00 -> $198.00||Medium|
|6/19/2017||Wells Fargo & Company||Reiterated Rating||Market Perform||$163.00 -> $174.00||Low|
|6/15/2017||CIBC||Boost Price Target||Outperform||$174.00 -> $185.00||Medium|
|6/15/2017||Oppenheimer Holdings, Inc.||Boost Price Target||Outperform||$174.00 -> $185.00||Low|
|6/1/2017||Cowen and Company||Reiterated Rating||Outperform||$160.00 -> $185.00||Low|
|5/15/2017||Stifel Nicolaus||Boost Price Target||Buy||$170.00 -> $175.00||N/A|
|9/26/2016||Leerink Swann||Reiterated Rating||Buy||$155.00||N/A|
|9/22/2016||Evercore ISI||Initiated Coverage||Hold||$134.00||N/A|
|9/8/2016||Goldman Sachs Group, Inc. (The)||Reiterated Rating||Buy||$160.00||N/A|
|8/31/2016||William Blair||Reiterated Rating||Buy||N/A|
|6/28/2016||Wolfe Research||Initiated Coverage||Outperform||$172.00||N/A|
|6/20/2016||FBR & Co||Reiterated Rating||Hold||N/A|
|6/1/2016||Barclays PLC||Boost Price Target||Equal Weight||$156.00 -> $168.00||N/A|
|1/24/2016||Sterne Agee CRT||Reiterated Rating||Buy||N/A|
|11/9/2015||Wedbush||Reiterated Rating||Hold||$186.00 -> $175.00||N/A|
Earnings History for Cigna Corporation (NYSE:CI)Earnings History by Quarter for Cigna Corporation (NYSE CI)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/4/2017||Q2 2017||$2.48||$2.91||$10.26 billion||$10.32 billion||View||N/A|
|5/5/2017||Q1 2017||$2.44||$2.77||$10.11 billion||$10.39 billion||View||N/A|
|2/2/2017||Q416||$1.74||$1.87||$9.88 billion||$9.94 billion||View||Listen|
|11/3/2016||Q316||$1.91||$1.94||$4.37 billion||$9.90 billion||View||N/A|
|7/29/2016||Q216||$2.39||$1.98||$9.98 billion||$9.89 billion||View||Listen|
|5/6/2016||Q116||$2.16||$2.32||$9.98 billion||$9.90 billion||View||N/A|
|2/4/2016||Q415||$1.80||$1.87||$9.52 billion||$9.53 billion||View||N/A|
|11/6/2015||Q315||$2.18||$2.28||$9.51 billion||$9.39 billion||View||N/A|
|7/30/2015||Q215||$2.38||$2.55||$9.53 billion||$9.50 billion||View||N/A|
|4/30/2015||Q115||$1.85||$1.96||$9.28 billion||$9.50 billion||View||N/A|
|2/5/2015||Q414||$1.65||$1.69||$8.89 billion||$8.93 billion||View||N/A|
|10/30/2014||Q314||$1.81||$1.95||$8.64 billion||$8.80 billion||View||N/A|
|7/31/2014||Q214||$1.85||$1.96||$7.61 billion||$8.73 billion||View||N/A|
|5/1/2014||Q114||$1.54||$1.83||$7.72 billion||$8.50 billion||View||Listen|
|2/7/2014||Q413||$1.63||$1.39||$7.30 billion||$8.15 billion||View||Listen|
|10/31/2013||Q313||$1.62||$1.89||$7.24 billion||$8.07 billion||View||Listen|
|8/1/2013||Q2 2013||$1.60||$1.78||$7.38 billion||$7.98 billion||View||N/A|
|5/2/2013||Q1 2013||$1.42||$1.72||$7.25 billion||$8.18 billion||View||Listen|
|2/7/2013||Q4 2012||$1.48||$1.41||$6.72 billion||$7.62 billion||View||Listen|
|11/1/2012||Q312||$1.36||$1.71||$6.63 billion||$7.36 billion||View||N/A|
Earnings Estimates for Cigna Corporation (NYSE:CI)
2017 EPS Consensus Estimate: $9.61
2018 EPS Consensus Estimate: $10.87
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Current Dividend Information for Cigna Corporation (NYSE:CI)
|Most Recent Dividend:||4/10/2017|
|Dividend Growth:||0.00% (3 Year Average)|
|Payout Ratio:||0.46% (Trailing 12 Months of Earnings) |
0.40% (Based on This Year's Estimates)
0.35% (Based on Next Year's Estimates)
Dividend History by Quarter for Cigna Corporation (NYSE CI)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Cigna Corporation (NYSE:CI)
Insider Ownership Percentage: 1.30%Insider Trades by Quarter for Cigna Corporation (NYSE:CI)
Institutional Ownership Percentage: 87.95%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/13/2017||William D. Zollars||Director||Sell||1,232||$187.23||$230,667.36|| |
|9/12/2017||Isaiah Harris, Jr.||Chairman||Sell||247||$185.27||$45,761.69|| |
|8/16/2017||Lisa R Bacus||EVP||Sell||2,236||$179.95||$402,368.20|| |
|8/9/2017||Mary T Hoeltzel||VP||Sell||525||$177.59||$93,234.75|| |
|8/8/2017||Michael W Triplett||Insider||Sell||3,700||$174.96||$647,352.00|| |
|8/7/2017||Jason D Sadler||Insider||Sell||37,756||$176.16||$6,651,096.96|| |
|7/24/2017||Jane E. Md Henney||Director||Sell||600||$174.14||$104,484.00|| |
|7/21/2017||Matthew G Manders||Insider||Sell||24,357||$175.01||$4,262,718.57|| |
|6/19/2017||David Cordani||CEO||Sell||153,168||$170.20||$26,069,193.60|| |
|6/14/2017||Michael W Triplett||Insider||Sell||1,439||$166.89||$240,154.71|| |
|6/6/2017||Mary T Hoeltzel||VP||Sell||500||$166.70||$83,350.00|| |
|6/5/2017||Jason D Sadler||Insider||Sell||1,727||$164.59||$284,246.93|| |
|6/2/2017||Matthew G Manders||Insider||Sell||6,000||$165.00||$990,000.00|| |
|5/24/2017||Lisa R Bacus||EVP||Sell||11,455||$161.57||$1,850,784.35|| |
|5/17/2017||Nicole S Jones||EVP||Sell||20,312||$160.04||$3,250,732.48|| |
|4/24/2017||Jane E. Md Henney||Director||Sell||600||$156.92||$94,152.00|| |
|4/10/2017||Jason D Sadler||Insider||Sell||4,213||$152.01||$640,418.13|| |
|2/27/2017||David Cordani||CEO||Sell||43,637||$147.78||$6,448,675.86|| |
|2/27/2017||Matthew G Manders||Insider||Sell||8,309||$146.54||$1,217,600.86|| |
|2/27/2017||Thomas A Mccarthy||CFO||Sell||4,464||$146.54||$654,154.56|| |
|12/20/2016||Jason D Sadler||Insider||Sell||2,000||$138.10||$276,200.00|| |
|11/7/2016||John M Murabito||EVP||Sell||58,822||$125.09||$7,358,043.98|| |
|10/31/2016||Jason D Sadler||Insider||Sell||4,000||$121.80||$487,200.00|| |
|8/17/2016||Mary T Hoeltzel||VP||Sell||500||$132.28||$66,140.00|| |
|12/8/2015||Isaiah Harris Jr||Chairman||Sell||333||$137.00||$45,621.00|| |
|11/16/2015||Herbert A. Fritch||insider||Sell||40,157||$133.18||$5,348,109.26|| |
|10/15/2015||Herbert A. Fritch||insider||Sell||39,202||$136.66||$5,357,345.32|| |
|9/15/2015||Herbert A. Fritch||insider||Sell||39,174||$139.66||$5,471,040.84|| |
|8/17/2015||Herbert A Fritch||Insider||Sell||38,489||$144.36||$5,556,272.04|| |
|7/15/2015||Herbert A Fritch||Insider||Sell||37,918||$155.96||$5,913,691.28|| |
|6/15/2015||Herbert A Fritch||Insider||Sell||38,045||$145.15||$5,522,231.75|| |
|6/8/2015||Isaiah Harris Jr||Chairman||Sell||319||$139.48||$44,494.12|| |
|4/15/2015||Herbert A Fritch||Insider||Sell||38,080||$132.99||$5,064,259.20|| |
|3/16/2015||Herbert A Fritch||Insider||Sell||38,377||$124.40||$4,774,098.80|| |
|3/9/2015||Isaiah Harris Jr||Chairman||Sell||369||$120.64||$44,516.16|| |
|3/2/2015||Nicole S Jones||EVP||Sell||8,659||$121.88||$1,055,358.92|| |
|2/10/2015||Mary T Hoeltzel||CAO||Sell||6,805||$113.29||$770,938.45|| |
|1/15/2015||Herbert A Fritch||Insider||Sell||35,864||$107.04||$3,838,882.56|| |
|12/15/2014||Herbert A Fritch||Insider||Sell||35,929||$101.67||$3,652,901.43|| |
|12/8/2014||Isaiah Harris Jr||Chairman||Sell||437||$104.60||$45,710.20|| |
|12/1/2014||John M Murabito||EVP||Sell||12,000||$102.76||$1,233,120.00|| |
|9/10/2014||Jane E Md Henney||Director||Sell||475||$95.98||$45,590.50|| |
|8/18/2014||Jason D Sadler||Insider||Sell||11,000||$93.02||$1,023,220.00|| |
|8/1/2014||Isaiah Harris Jr||Chairman||Sell||1,066||$90.22||$96,174.52|| |
|6/13/2014||Thomas A Mccarthy||CFO||Sell||7,206||$90.26||$650,413.56|| |
|6/12/2014||Nicole S Jones||EVP||Sell||1,882||$91.02||$171,299.64|| |
|6/11/2014||John M Murabito||EVP||Sell||17,519||$91.25||$1,598,608.75|| |
|6/10/2014||David Cordani||CEO||Sell||133,523||$89.73||$11,981,018.79|| |
|6/2/2014||David D Guilmette||Insider||Sell||6,591||$90.19||$594,442.29|| |
|5/13/2014||Jason Sadler||Insider||Sell||6,145||$88.50||$543,832.50|| |
|5/12/2014||Matthew Manders||Insider||Sell||9,905||$87.79||$869,559.95|| |
|5/8/2014||Jason Sadler||Insider||Sell||7,810||$85.59||$668,457.90|| |
|5/7/2014||Mary Hoeltzel||CAO||Sell||3,000||$85.00||$255,000.00|| |
|3/14/2014||John Murabito||EVP||Sell||29,843||$76.70||$2,288,958.10|| |
|3/14/2014||Mary Hoeltzel||CAO||Sell||5,333||$77.72||$414,480.76|| |
|9/12/2013||Nicole Jones||EVP||Sell||1,530||$82.35||$125,995.50|| |
|9/6/2013||John M Murabito||EVP||Sell||24,333||$81.07||$1,972,676.31|| |
|8/16/2013||Jason Sadler||Insider||Sell||13,261||$77.81||$1,031,838.41|| |
|8/14/2013||Mary Hoeltzel||CAO||Sell||8,664||$78.26||$678,044.64|| |
|8/7/2013||John Murabito||EVP||Sell||78,589||$77.89||$6,121,297.21|| |
|6/13/2013||David Cordani||CEO||Sell||58,705||$68.63||$4,028,924.15|| |
|6/12/2013||Matthew G Manders||Insider||Sell||36,868||$68.75||$2,534,675.00|| |
|6/12/2013||Nicole S Jones||EVP||Sell||15,306||$70.08||$1,072,644.48|| |
|6/5/2013||Isaiah Harris Jr||Chairman||Sell||5,312||$67.40||$358,028.80|| |
|3/11/2013||Mary T Hoeltzel||CAO||Sell||5,712||$60.50||$345,576.00|| |
|3/6/2013||Eric C Wiseman||Director||Buy||4,200||$59.30||$249,060.00|| |
Headline Trends for Cigna Corporation (NYSE:CI)
Latest Headlines for Cigna Corporation (NYSE:CI)
Cigna Corporation (CI) Chart for Tuesday, October, 17, 2017